BioView

Our Mission is to improve cancer patients assessments and outcomes. BioView develops, manufactures, and markets innovative Automated cell imaging and analysis platforms for use in cytology, cytogenetics and pathology at clinical and research laboratories who wish to digitize and streamline their analysis workflow. BioViews industry-leading platforms offer advanced capabilities for Fluorescent and Bright-field based applications driven by Artificial intelligence. Starting from automated FISH Analysis of tissue and cells suspension for cancer and genetic abnormalities, to automated whole slide imaging for digital pathology and quantitative IHC scoring application for nuclear & membrane staining. Bringing liquid Biopsy to the clinical Practice We...

Fish analysis,circulating tumor cells detection,digital pathology,karyotyping,target fish,alk fish,ros1 fish,cll fish,her2neu fish,fish web analysis,ai based image analysis,cloud applications,liquid biopsy,and rare cells

Bioview operates in the Medical equipment manufacturing industry.

Bioview's revenue is 11m - 100m

Bioview has 11 - 50 employees.